Sam Chun Dang Pharm. Co. Ltd Capital Reinvestment Ratio
Sam Chun Dang Pharm. Co. Ltd capital reinvestment ratio. Sam Chun Dang Pharm. Co. Ltd (000250) has a Capital Reinvestment Ratio of 1.86x as of June 2026, meaning it reinvests 2% of its operating cash flow (₩12.04 Billion) in capital expenditures (₩22.36 Billion). Check cash flow reinvestment rate of Sam Chun Dang Pharm. Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sam Chun Dang Pharm. Co. Ltd (2012–2025)
Capital reinvestment ratio of Sam Chun Dang Pharm. Co. Ltd from 2012 to 2025. This chart tracks Sam Chun Dang Pharm. Co. Ltd's Capital Reinvestment Ratio across 13 annual periods. Also explore 000250 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Sam Chun Dang Pharm. Co. Ltd Capital Reinvestment Ratio by Year (2012–2025)
Sam Chun Dang Pharm. Co. Ltd capital reinvestment ratio by year from 2012 to 2025. For the full cash flow conversion analysis, see 000250 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 6.08x | ₩9.79 Billion | ₩59.59 Billion | ▲ +220.7% |
| 2024 | 1.90x | ₩21.77 Billion | ₩41.30 Billion | ▲ +102.3% |
| 2023 | 0.94x | ₩23.43 Billion | ₩21.97 Billion | ▼ -73.2% |
| 2022 | 3.51x | ₩13.28 Billion | ₩46.55 Billion | ▲ +31.3% |
| 2020 | 2.67x | ₩3.25 Billion | ₩8.68 Billion | ▲ +1139.4% |
| 2019 | 0.22x | ₩30.60 Billion | ₩6.59 Billion | ▼ -53.3% |
| 2018 | 0.46x | ₩25.03 Billion | ₩11.55 Billion | ▲ +270.1% |
| 2017 | 0.12x | ₩26.09 Billion | ₩3.25 Billion | ▼ -75.7% |
| 2016 | 0.51x | ₩17.76 Billion | ₩9.11 Billion | ▼ -19.0% |
| 2015 | 0.63x | ₩17.34 Billion | ₩10.97 Billion | ▲ +41.9% |
| 2014 | 0.45x | ₩19.55 Billion | ₩8.72 Billion | ▲ +65.9% |
| 2013 | 0.27x | ₩15.94 Billion | ₩4.28 Billion | ▼ -84.9% |
| 2012 | 1.79x | ₩1.60 Billion | ₩2.86 Billion | — |